健民集团：关于获得《药物临床试验批准通知书》的公告

Core Viewpoint - Jianmin Group has received the clinical trial approval notice for its nasal medication, indicating progress in its product development pipeline [2] Company Summary - Jianmin Group announced on August 14 that it has obtained the clinical trial approval from the National Medical Products Administration for its nasal medication, Nasal Congestion Relief Granules [2]